BIB

Ultra Nasdaq Biotechnology

Investment Objective

ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®.

You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)

Performance

Daily Return during Q1 2024

Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker BIB
  • Intraday Ticker BIB.IV
  • CUSIP 74347R214
  • Inception Date 4/7/10
  • Gross Expense Ratio 1.15%
  • Net Expense Ratio 0.95%
  • NAV Calculation Time 4:00 p.m. ET
  • Distributions Quarterly
Price
as of 3/28/2024
  • NAV $57.53
  • NAV Change $-0.42 down caret
  • Market Price $57.54
  • Market Price Change $-0.55 down caret
  • Trading Volume (M) 34,738
  • 30-Day Median Bid Ask Spread 0.00%
  • View Premium / Discount
Snapshot
  • Ticker BIB
  • Intraday Ticker BIB.IV
  • CUSIP 74347R214
  • Inception Date 4/7/10
  • Expense Ratio 0.95%
  • Gross Expense Ratio 1.15%
  • NAV Calculation Time 4:00 p.m. ET
  • Distributions Quarterly
Price
as of 3/28/2024
  • NAV $57.53
  • NAV Change $-0.42 down caret
  • Market Price $57.54
  • Market Price Change $-0.55 down caret
  • Trading Volume (M) 34,738
  • 30-Day Median Bid Ask Spread 0.00%
  • View Premium / Discount

The expense ratio above has a contractual waiver ending 9/30/24.

Exposures

Index as of 12/29/2023

Holdings

as of 3/28/2024

Exposure Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts SEDOL Number
50.80% -- NASDAQ BIO INDEX SWAP BNP 50,413,059 -- 11,380 --
26.82% -- NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG 26,610,830 -- 6,007 --
23.04% -- NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE 22,867,505 -- 5,162 --
14.88% -- NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA 14,769,520 -- 3,334 --
5.99% AMGN AMGEN INC -- $5,939,444.80 20,890 2023607
5.90% -- NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL 5,851,990 -- 1,321 --
5.86% GILD GILEAD SCIENCES INC -- $5,811,508.50 79,338 2369174
5.74% REGN REGENERON PHARMACEUTICALS -- $5,698,903.29 5,921 2730190
5.73% VRTX VERTEX PHARMACEUTICALS INC -- $5,683,263.96 13,596 2931034
4.65% -- NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA 4,616,029 -- 1,042 --
3.05% -- NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLC 3,025,670 -- 683 --
3.00% MRNA MODERNA INC -- $2,973,130.56 27,901 BGSXTS3
2.90% AZN ASTRAZENECA PLC-SPONS ADR -- $2,880,865.50 42,522 2989044
2.31% BIIB BIOGEN INC -- $2,288,912.45 10,615 2455965
1.61% ILMN ILLUMINA INC -- $1,593,323.96 11,603 2613990
1.39% ALNY ALNYLAM PHARMACEUTICALS INC -- $1,374,491.65 9,197 B00FWN1
1.21% BMRN BIOMARIN PHARMACEUTICAL INC -- $1,203,283.18 13,777 2437071
1.04% VTRS VIATRIS INC -- $1,035,436.80 86,720 BMWS3X9
1.01% NBIX NEUROCRINE BIOSCIENCES INC -- $1,002,264.64 7,267 2623911
1.00% RPRX ROYALTY PHARMA PLC- CL A -- $990,639.03 32,619 BMVP7Y0
0.98% SNY SANOFI-ADR -- $972,145.80 20,003 2964557
0.94% INCY INCYTE CORP -- $934,080.12 16,396 2471950
0.91% MEDP MEDPACE HOLDINGS INC -- $907,720.90 2,246 BDCBC61
0.90% ARGX ARGENX SE - ADR -- $894,925.56 2,273 BDVLM39
0.89% SRPT SAREPTA THERAPEUTICS INC -- $887,318.84 6,854 B8DPDT7
0.80% UTHR UNITED THERAPEUTICS CORP -- $789,547.64 3,437 2430412
0.66% BNTX BIONTECH SE-ADR -- $652,299.75 7,071 BK6H543
0.64% ASND ASCENDIS PHARMA A/S - ADR -- $633,855.81 4,193 BV9G6B8
0.63% ROIV ROIVANT SCIENCES LTD -- $620,236.84 58,846 BMW4NZ9
0.55% JAZZ JAZZ PHARMACEUTICALS PLC -- $548,151.84 4,552 B4Q5ZN4
0.54% PCVX VAXCYTE INC -- $540,741.96 7,916 BKPVGH6
0.53% CYTK CYTOKINETICS INC -- $527,297.31 7,521 BBBSBJ5
0.53% EXEL EXELIXIS INC -- $525,405.93 22,141 2576941
0.52% APLS APELLIS PHARMACEUTICALS INC -- $517,616.68 8,806 BYTQ6X1
0.49% ITCI INTRA-CELLULAR THERAPIES INC -- $489,244.00 7,070 BHCB0P4
0.48% BGNE BEIGENE LTD-ADR -- $472,923.36 3,024 BYYWPW6
0.46% IONS IONIS PHARMACEUTICALS INC -- $461,417.40 10,644 BDJ0LS6
0.43% BPMC BLUEPRINT MEDICINES CORP -- $424,213.92 4,472 BWY52P3
0.40% CRSP CRISPR THERAPEUTICS AG -- $399,553.92 5,862 BDHF4K6
0.40% BBIO BRIDGEBIO PHARMA INC -- $397,012.80 12,840 BK1KWG8
0.39% MDGL MADRIGAL PHARMACEUTICALS INC -- $388,009.12 1,453 BD59BS7
0.39% RVMD REVOLUTION MEDICINES INC -- $387,630.21 12,027 BL71K91
0.38% HALO HALOZYME THERAPEUTICS INC -- $376,737.48 9,261 2975098
0.37% KRYS KRYSTAL BIOTECH INC -- $367,603.38 2,066 BD6JX35
0.35% IMVT IMMUNOVANT INC -- $342,809.10 10,610 BJRFSB7
0.33% ALKS ALKERMES PLC -- $330,254.00 12,200 B3P6D26
0.33% LEGN LEGEND BIOTECH CORP-ADR -- $326,387.71 5,819 BMX9K07
0.32% NUVL NUVALENT INC-A -- $321,535.38 4,282 BMVBZD3
0.30% IOVA IOVANCE BIOTHERAPEUTICS INC -- $302,268.72 20,396 BF0DMK7
0.30% INSM INSMED INC -- $294,170.59 10,843 2614487
0.28% RARE ULTRAGENYX PHARMACEUTICAL IN -- $280,746.97 6,013 BJ62Z18
0.28% AXSM AXSOME THERAPEUTICS INC -- $276,028.20 3,459 BYZR4X4
0.27% ACLX ARCELLX INC -- $268,115.25 3,855 BPCJ1Q2
0.27% SWTX SPRINGWORKS THERAPEUTICS INC -- $265,197.36 5,388 BGMGM89
0.26% IBRX IMMUNITYBIO INC -- $261,830.46 48,758 BNSP0B8
0.26% FTRE FORTREA HOLDINGS INC -- $260,267.76 6,484 BRXYZ57
0.26% ARWR ARROWHEAD PHARMACEUTICALS IN -- $258,772.80 9,048 BYQBFJ8
0.26% FOLD AMICUS THERAPEUTICS INC -- $254,094.60 21,570 B19FQ48
0.24% IDYA IDEAYA BIOSCIENCES INC -- $238,882.72 5,444 BK0VHF6
0.24% CRNX CRINETICS PHARMACEUTICALS IN -- $237,935.23 5,083 BDD19F8
0.24% XENE XENON PHARMACEUTICALS INC -- $237,119.40 5,508 BRJ3GY4
0.22% ACAD ACADIA PHARMACEUTICALS INC -- $222,490.17 12,033 2713317
0.21% SMMT SUMMIT THERAPEUTICS INC -- $212,137.74 51,241 BMTVQS7
0.21% DNLI DENALI THERAPEUTICS INC -- $208,524.24 10,162 BD2B4V0
0.21% ARVN ARVINAS INC -- $205,244.16 4,972 BDZ30Q0
0.20% BEAM BEAM THERAPEUTICS INC -- $197,017.52 5,963 BK6L288
0.19% NTLA INTELLIA THERAPEUTICS INC -- $193,065.18 7,018 BYZM6C2
0.19% MRUS MERUS NV -- $190,341.81 4,227 BZBY005
0.19% RYTM RHYTHM PHARMACEUTICALS INC -- $190,262.03 4,391 BF2YWG4
0.19% ALPN ALPINE IMMUNE SCIENCES INC -- $189,717.04 4,786 BYX38M1
0.18% VCEL VERICEL CORP -- $183,422.52 3,526 BSBMN89
0.18% GH GUARDANT HEALTH INC -- $183,359.44 8,888 BFXC911
0.18% APGE APOGEE THERAPEUTICS INC -- $180,411.75 2,715 BM9HHL5
0.18% KYMR KYMERA THERAPEUTICS INC -- $179,412.60 4,463 BMPRZV5
0.18% RCKT ROCKET PHARMACEUTICALS INC -- $178,046.46 6,609 BDFKQ07
0.18% KROS KEROS THERAPEUTICS INC -- $173,973.60 2,628 BM7V485
0.17% DYN DYNE THERAPEUTICS INC -- $168,153.97 5,923 BN15WD1
0.17% RXRX RECURSION PHARMACEUTICALS-A -- $165,372.39 16,587 BM9FJ13
0.17% VERA VERA THERAPEUTICS INC -- $165,322.08 3,834 BL55460
0.16% IMCR IMMUNOCORE HOLDINGS PLC-ADR -- $163,670.00 2,518 BLCD809
0.16% PTCT PTC THERAPEUTICS INC -- $162,729.46 5,594 B17VCN9
0.16% SANA SANA BIOTECHNOLOGY INC -- $160,980.00 16,098 BMFJJ97
0.16% AMPH AMPHASTAR PHARMACEUTICALS IN -- $154,211.92 3,512 BNFWZS4
0.15% GPCR STRUCTURE THERAPEUTICS INC -- $152,410.16 3,556 BQS9486
0.15% RNA AVIDITY BIOSCIENCES INC -- $148,577.44 5,822 BMWHPY1
0.15% SNDX SYNDAX PHARMACEUTICALS INC -- $147,679.00 6,205 BN7Q7R7
0.15% TWST TWIST BIOSCIENCE CORP -- $144,856.82 4,222 BGKG6G7
0.14% MYGN MYRIAD GENETICS INC -- $139,923.16 6,563 2614153
0.14% HRMY HARMONY BIOSCIENCES HOLDINGS -- $139,189.10 4,145 BKSGZN7
0.14% JANX JANUX THERAPEUTICS INC -- $139,154.40 3,696 BMFX8Y7
0.14% SUPN SUPERNUS PHARMACEUTICALS INC -- $136,303.56 3,996 B72ZBG4
0.13% GERN GERON CORP -- $131,587.50 39,875 2370381
0.13% MORF MORPHIC HOLDING INC -- $128,620.80 3,654 BK8M4J4
0.13% ARDX ARDELYX INC -- $124,041.60 16,992 BN89V40
0.12% EWTX EDGEWISE THERAPEUTICS INC -- $124,013.76 6,799 BKY5JZ8
0.12% PTGX PROTAGONIST THERAPEUTICS INC -- $123,097.15 4,255 BDCBCD8
0.12% NVCR NOVOCURE LTD -- $122,226.60 7,820 BYSS4X4
0.12% VCYT VERACYTE INC -- $121,481.12 5,482 BFTWZY0
0.12% INBX INHIBRX INC -- $120,996.56 3,461 BK1MBC3
0.12% AGIO AGIOS PHARMACEUTICALS INC -- $119,971.72 4,103 BCBVTX1
0.12% KURA KURA ONCOLOGY INC -- $118,594.80 5,560 BYZD465
0.12% DVAX DYNAVAX TECHNOLOGIES CORP -- $118,366.58 9,538 BRJZSK0
0.12% FDMT 4D MOLECULAR THERAPEUTICS IN -- $115,811.10 3,635 BKLXFX5
0.11% FUSN FUSION PHARMACEUTICALS INC -- $112,718.84 5,287 BJK0NH0
0.11% AVDL AVADEL PHARMACEUTICALS-ADR -- $110,680.17 6,553 BDTZ028
0.11% ADMA ADMA BIOLOGICS INC -- $109,989.00 16,665 B9NSBM2
0.11% IRON DISC MEDICINE INC -- $109,702.12 1,762 BMGJZJ8
0.11% ANIP ANI PHARMACEUTICALS INC -- $106,321.94 1,538 BCDWBX6
0.11% DAWN DAY ONE BIOPHARMACEUTICALS I -- $105,414.12 6,381 BLB0YH0
0.10% AKRO AKERO THERAPEUTICS INC -- $103,843.86 4,111 BK7Y2V9
0.10% VIR VIR BIOTECHNOLOGY INC -- $99,881.80 9,860 BK4PZ38
0.10% IRWD IRONWOOD PHARMACEUTICALS INC -- $99,564.01 11,431 B3MZ6K5
0.10% PCRX PACIRA BIOSCIENCES INC -- $99,231.12 3,396 B3X26D8
0.10% XNCR XENCOR INC -- $98,766.19 4,463 BGCYWN8
0.10% PRTA PROTHENA CORP PLC -- $97,172.71 3,923 B91XRN2
0.10% ABCL ABCELLERA BIOLOGICS INC -- $96,851.40 21,380 BL53SR3
0.10% LGND LIGAND PHARMACEUTICALS -- $94,518.30 1,293 2501578
0.09% SRRK SCHOLAR ROCK HOLDING CORP -- $93,559.68 5,268 BFZQ0L8
0.09% DCPH DECIPHERA PHARMACEUTICALS IN -- $92,807.00 5,900 BZ1LFB2
0.09% GMAB GENMAB A/S -SP ADR -- $91,584.42 3,062 BBC9WC7
0.09% TARS TARSUS PHARMACEUTICALS INC -- $90,838.65 2,499 BMH5RL1
0.09% COLL COLLEGIUM PHARMACEUTICAL INC -- $90,605.88 2,334 BX7RSN3
0.09% MNKD MANNKIND CORP -- $89,453.91 19,747 BF081J4
0.09% MIRM MIRUM PHARMACEUTICALS INC -- $85,508.48 3,404 BJDX8Y8
0.08% MRVI MARAVAI LIFESCIENCES HLDGS-A -- $83,760.87 9,661 BMCWKZ2
0.08% SAGE SAGE THERAPEUTICS INC -- $82,268.60 4,390 BP4GNK9
0.08% ZNTL ZENTALIS PHARMACEUTICALS INC -- $81,668.32 5,182 BMQ5T49
0.08% VERV VERVE THERAPEUTICS INC -- $81,087.68 6,106 BNKGXX2
0.08% VRNA VERONA PHARMA PLC - ADR -- $79,838.58 4,962 BYWPZK5
0.08% RLAY RELAY THERAPEUTICS INC -- $79,505.70 9,579 BN2R582
0.08% ETNB 89BIO INC -- $79,221.84 6,806 BK1K484
0.08% BCRX BIOCRYST PHARMACEUTICALS INC -- $76,474.32 15,054 2100362
0.07% EYPT EYEPOINT PHARMACEUTICALS INC -- $73,709.22 3,566 BMGS7L1
0.07% PACB PACIFIC BIOSCIENCES OF CALIF -- $73,376.25 19,567 B4N8MH9
0.07% OCUL OCULAR THERAPEUTIX INC -- $73,245.90 8,049 BNZB1X8
0.07% SPRY ARS PHARMACEUTICALS INC -- $71,642.20 7,010 BMCR7V2
0.07% INVA INNOVIVA INC -- $70,363.08 4,617 BDDXF67
0.07% ARQT ARCUTIS BIOTHERAPEUTICS INC -- $70,063.70 7,070 BKX9VD3
0.07% RGNX REGENXBIO INC -- $68,372.15 3,245 BZ0G875
0.07% ORIC ORIC PHARMACEUTICALS INC -- $67,636.25 4,919 BKVDFF7
0.07% MGNX MACROGENICS INC -- $66,681.60 4,530 BFDV8K0
0.07% ARCT ARCTURUS THERAPEUTICS HOLDIN -- $65,919.04 1,952 BKC9SX3
0.07% AUTL AUTOLUS THERAPEUTICS PLC -- $65,573.64 10,278 BFMLGR4
0.07% PLRX PLIANT THERAPEUTICS INC -- $65,545.10 4,399 BMDWW66
0.07% BCYC BICYCLE THERAPEUTICS PLC-ADR -- $64,889.40 2,606 BKDQKM6
0.06% PRME PRIME MEDICINE INC -- $59,570.00 8,510 BPBJFM7
0.06% GRFS GRIFOLS SA-ADR -- $59,505.44 8,908 B8K7T65
0.06% TNGX TANGO THERAPEUTICS INC -- $59,137.12 7,448 BP2P6L0
0.06% EOLS EVOLUS INC -- $58,422.00 4,173 BDRJH21
0.06% ZLAB ZAI LAB LTD-ADR -- $57,944.34 3,617 BD9GVY0
0.06% KNSA KINIKSA PHARMACEUTICALS-A -- $57,591.87 2,919 BD0MGM0
0.06% WVE WAVE LIFE SCIENCES LTD -- $54,987.04 8,912 BYZG9R0
0.06% ALLO ALLOGENE THERAPEUTICS INC -- $54,927.36 12,288 BFZNYB7
0.05% ZYME ZYMEWORKS INC -- $53,778.24 5,112 BPCQZY9
0.05% CABA CABALETTA BIO INC -- $53,380.74 3,129 BK5MWR1
0.05% CGEM CULLINAN ONCOLOGY INC -- $53,232.96 3,124 BM90J52
0.05% ELVN ENLIVEN THERAPEUTICS INC -- $52,928.31 3,009 BMFD115
0.05% AUPH AURINIA PHARMACEUTICALS INC -- $52,905.60 10,560 BFWLC09
0.05% NRIX NURIX THERAPEUTICS INC -- $52,479.00 3,570 BMVLGP2
0.05% YMAB Y-MABS THERAPEUTICS INC -- $51,983.22 3,197 BG31GH0
0.05% COGT COGENT BIOSCIENCES INC -- $50,991.36 7,588 BLR6XK8
0.05% CVAC CUREVAC NV -- $49,543.53 16,351 BN4RD42
0.05% SVRA SAVARA INC -- $49,217.34 9,883 BYXGN81
0.05% NVAX NOVAVAX INC -- $48,851.60 10,220 BJDQXG4
0.05% SLRN ACELYRIN INC -- $47,979.00 7,108 BQPF874
0.05% CNTA CENTESSA PHARMACEUTICALS-ADR -- $46,522.10 4,117 BLB0YQ9
0.05% GLPG GALAPAGOS NV-SPON ADR -- $46,400.20 1,441 B292NQ7
0.05% OABI OMNIAB INC -- $46,004.96 8,488 BN13S71
0.05% OLMA OLEMA PHARMACEUTICALS INC -- $45,540.36 4,023 BMZ4LN0
0.04% SIGA SIGA TECHNOLOGIES INC -- $44,434.96 5,191 2107437
0.04% CSTL CASTLE BIOSCIENCES INC -- $44,410.75 2,005 BKLCWZ3
0.04% PHAT PHATHOM PHARMACEUTICALS INC -- $44,402.22 4,181 BJLKVS6
0.04% EDIT EDITAS MEDICINE INC -- $44,334.50 5,975 BZ8FPH3
0.04% ANAB ANAPTYSBIO INC -- $43,711.32 1,941 BDRW1L7
0.04% TRML TOURMALINE BIO INC -- $42,868.80 1,872 BQ80NC6
0.04% TVTX TRAVERE THERAPEUTICS INC -- $42,844.47 5,557 BLFGJD5
0.04% LXRX LEXICON PHARMACEUTICALS INC -- $42,768.00 17,820 BWFZX59
0.04% FULC FULCRUM THERAPEUTICS INC -- $42,697.12 4,523 BJDX8Z9
0.04% ALEC ALECTOR INC -- $42,091.84 6,992 BJ4LDC4
0.04% LYEL LYELL IMMUNOPHARMA INC -- $41,377.65 18,555 BN6MB18
0.04% ALXO ALX ONCOLOGY HOLDINGS INC -- $40,563.70 3,638 BLN7XQ1
0.04% TSHA TAYSHA GENE THERAPIES INC -- $39,184.11 13,653 BNC1BX1
0.04% BMEA BIOMEA FUSION INC -- $38,974.65 2,607 BNKF6N0
0.04% PETQ PETIQ INC -- $38,972.96 2,132 BDH65C8
0.04% MLYS MINERALYS THERAPEUTICS INC -- $38,755.82 3,002 BP9N0G0
0.04% HCM HUTCHMED CHINA-ADR -- $38,052.00 2,265 BYXV9H7
0.04% VYGR VOYAGER THERAPEUTICS INC -- $36,914.15 3,965 BY7RB53
0.04% REPL REPLIMUNE GROUP INC -- $36,626.11 4,483 BDDVW37
0.04% MRNS MARINUS PHARMACEUTICALS INC -- $36,024.40 3,985 BM8MVZ3
0.04% KALV KALVISTA PHARMACEUTICALS INC -- $36,006.96 3,036 BD06CS0
0.04% ITOS ITEOS THERAPEUTICS INC -- $35,641.32 2,613 BMWXFT4
0.03% ADPT ADAPTIVE BIOTECHNOLOGIES -- $34,009.95 10,595 BJ5FZ74
0.03% HROW HARROW INC -- $33,921.72 2,564 BHNDW86
0.03% URGN UROGEN PHARMA LTD -- $33,810.00 2,254 BZ7PJQ1
0.03% CRBU CARIBOU BIOSCIENCES INC -- $33,194.12 6,458 BNYJR68
0.03% TBPH THERAVANCE BIOPHARMA INC -- $32,623.89 3,637 BMNDK09
0.03% RVNC REVANCE THERAPEUTICS INC -- $31,694.64 6,442 BJFSR99
0.03% MXCT MAXCYTE INC -- $31,693.16 7,564 BKMQF66
0.03% ABUS ARBUTUS BIOPHARMA CORP -- $31,594.68 12,246 BZ0QMB7
0.03% AVXL ANAVEX LIFE SCIENCES CORP -- $30,519.64 5,996 BYTYP72
0.03% TERN TERNS PHARMACEUTICALS INC -- $29,598.72 4,512 BMDJ0C9
0.03% MGTX MEIRAGTX HOLDINGS PLC -- $28,189.08 4,644 BFYQFJ2
0.03% THRD THIRD HARMONIC BIO INC -- $27,829.12 2,948 BNNPQY8
0.03% NAUT NAUTILUS BIOTECHNOLOGY INC -- $26,856.90 9,135 BNG1NK8
0.03% PGEN PRECIGEN INC -- $26,356.65 18,177 BKM5C84
0.03% AMRN AMARIN CORP PLC -ADR -- $25,099.18 28,176 2301938
0.03% AVIR ATEA PHARMACEUTICALS INC -- $24,829.84 6,146 BLN9Z50
0.02% ATAI ATAI LIFE SCIENCES NV -- $23,882.31 12,123 BN6M8F1
0.02% VTYX VENTYX BIOSCIENCES INC -- $23,798.50 4,327 BMG99Y1
0.02% HUMA HUMACYTE INC -- $23,524.04 7,564 BMYTJP4
0.02% ERAS ERASCA INC -- $22,727.98 11,033 BNLYBF3
0.02% RAPT RAPT THERAPEUTICS INC -- $22,548.78 2,511 BK5T6R0
0.02% XERS XERIS BIOPHARMA HOLDINGS INC -- $22,292.27 10,087 BLR7H87
0.02% ACIU AC IMMUNE SA -- $21,356.40 7,215 BZC0D70
0.02% EXAI EXSCIENTIA PLC -- $20,151.56 3,523 BP48134
0.02% CHRS COHERUS BIOSCIENCES INC -- $19,435.48 8,132 BRK0149
0.02% PAHC PHIBRO ANIMAL HEALTH CORP-A -- $19,201.05 1,485 BL95N25
0.02% QURE UNIQURE NV -- $18,168.80 3,494 BJFSR88
0.02% BLUE BLUEBIRD BIO INC -- $17,793.28 13,901 BBFL7S1
0.02% VNDA VANDA PHARMACEUTICALS INC -- $17,266.11 4,201 B12W3P6
0.02% OVID OVID THERAPEUTICS INC -- $15,741.05 5,161 BYPFK63
0.01% AMLX AMYLYX PHARMACEUTICALS INC -- $14,055.16 4,949 BPCK358
0.01% ME 23ANDME HOLDING CO -CLASS A -- $12,254.62 23,035 BM9CKX3
0.01% -- ACHILLION PHARMACEUTICALS INC - CVR -- $11,641.22 25,307 --
0.01% ACRS ACLARIS THERAPEUTICS INC -- $6,423.20 5,180 BYV2W40
-- RPHM RENEO PHARMACEUTICALS INC -- $4,038.78 2,433 BMHR7T5
-- 2324462D CARTESIAN THERAPEUTICS-CVR -- $1,761.30 9,785 BM9HFX3
-- -- TREASURY BILL -- $14,724,867.15 15,000,000 BRYQ9Y9
-- -- NET OTHER ASSETS (LIABILITIES) -- $13,919,365.78 13,919,366 --

Index

as of 12/29/2023

  • Total Number of Companies225
  • Price/Earnings Ratio--
  • Price/Book Ratio4.289
  • Dividend Yield ( % )0.79
  • Avg. Index Market Capitalization$6.63 billion
About the Index

The Nasdaq Biotechnology Index is a modified capitalization weighted index that includes securities of The Nasdaq Stock Market listed companies that are classified as either biotechnology or pharmaceutical. The securities also meet other eligibility criteria determined by The Nasdaq OMX Group, Inc., including minimum market capitalization and liquidity requirements.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital

Portfolio Hedging Series

Part I: The Significance of Portfolio Hedging

Investing involves risk. Market downturns will happen. Having a sound investment strategy can help smooth out the turbulence in your portfolio and save you from getting caught up in a herd mentality of selling low into a down market.
Read More
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”). While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target. The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

There is no guarantee that capital gain distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

Technology companies may be subject to intense competition, product obsolescence, general economic conditions and government regulation and may have limited product lines, markets, financial resources or personnel.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

The "Nasdaq Biotechnology Index®" is a trademark of The Nasdaq OMX Group, Inc. ("Nasdaq OMX") and has been licensed for use by ProShares. ProShares have not been passed on by Nasdaq OMX or its subsidiaries or affiliates as to their legality or suitability. ProShares based on the Nasdaq Biotechnology Index are not sponsored, endorsed, sold or promoted by Nasdaq OMX or its subsidiaries or affiliates, and they make no representation regarding the advisability of investing in ProShares. THIS ENTITY AND ITS AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds’ advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.